Loading...

BB Biotech AG

BBZA.DEXETRA
Healthcare
Biotechnology
34.30
-0.30(-0.87%)

BB Biotech AG (BBZA.DE) Financial Performance & Income Statement Overview

Review BB Biotech AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
155.94%
155.94%
Operating Income Growth
382.01%
382.01%
Net Income Growth
136.74%
136.74%
Operating Cash Flow Growth
39.53%
39.53%
Operating Margin
68.07%
68.07%
Gross Margin
100.00%
100.00%
Net Profit Margin
263.05%
263.05%
ROE
-19.24%
19.24%
ROIC
-5.66%
5.66%

BB Biotech AG (BBZA.DE) Income Statement & Financial Overview

Review BB Biotech AG's (BBZA.DE) income statement with detailed quarterly and annual figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$108000.00$67.14M-$149.69M-$79.33M
Cost of Revenue$0.00$0.00-$1.24M-$79.36M
Gross Profit$108000.00$67.14M-$148.45M$32000.00
Gross Profit Ratio$1.00$1.00$0.99-$0.00
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$6.08M$6.43M$7.46M$7.73M
Operating Expenses$6.08M$6.43M$6.57M$7.73M
Total Costs & Expenses$6.08M$6.43M$7.46M$7.73M
Interest Income$0.00$0.00$0.00$32000.00
Interest Expense$0.00$0.00$1.20M$1.57M
Depreciation & Amortization$6.07M-$59.78M$0.00$7.70M
EBITDA$0.00$0.00$0.00-$78.73M
EBITDA Ratio$0.00$0.00$0.00$0.99
Operating Income-$5.97M$60.70M-$157.15M-$87.06M
Operating Income Ratio-$55.26$0.90$1.05$1.10
Other Income/Expenses (Net)-$234.95M-$1.05M-$150.58M-$79.36M
Income Before Tax-$240.92M$59.65M-$157.15M-$87.06M
Income Before Tax Ratio-$2230.73$0.89$1.05$1.10
Income Tax Expense$15000.00$3000.00$19000.00$19000.00
Net Income-$240.93M$59.66M-$157.17M-$87.08M
Net Income Ratio-$2230.87$0.89$1.05$1.10
EPS-$4.40$1.08-$2.87-$1.60
Diluted EPS-$4.40$1.09-$2.87-$1.60
Weighted Avg Shares Outstanding$54.74M$55.21M$54.76M$54.43M
Weighted Avg Shares Outstanding (Diluted)$54.74M$54.80M$54.76M$54.43M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;